Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.

[1]  G. Luca,et al.  Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty☆ , 2004 .

[2]  A. Colombo,et al.  A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[3]  M. Napodano,et al.  Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[4]  H. Suryapranata,et al.  Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. , 2003, Journal of the American College of Cardiology.

[5]  AlbertSchömig,et al.  Therapy-Dependent Influence of Time-to-Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis , 2003 .

[6]  P. Armstrong,et al.  ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction. , 2003, European heart journal.

[7]  R. Gibbons,et al.  Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. , 2002, European heart journal.

[8]  J. Ottervanger,et al.  Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. , 2002, European heart journal.

[9]  E. Antman,et al.  Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II. , 2002, European heart journal.

[10]  David Antoniucci,et al.  Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. , 2002, The American journal of cardiology.

[11]  R. Gibbons,et al.  Clinical characteristics and outcome of patients with early ( 4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. , 2002 .

[12]  K. Wegscheider,et al.  Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction , 2001, The Lancet.

[13]  G. Stone,et al.  Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction: Analysis From the Primary Angioplasty in Myocardial Infarction Trials , 2001, Circulation.

[14]  C. Cannon,et al.  Importance of TIMI 3 flow. , 2001, Circulation.

[15]  G. Bernardi,et al.  [Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[16]  C M Gibson,et al.  Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. , 2000, JAMA.

[17]  E. Antman,et al.  Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. , 2000, Circulation.

[18]  R. Califf,et al.  Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. , 1999, Circulation.

[19]  C. Vrints,et al.  Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. , 1999, Circulation.

[20]  B. Brodie,et al.  Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. , 1998, Journal of the American College of Cardiology.

[21]  H. Suryapranata,et al.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. , 1998, Circulation.

[22]  Y. Taniyama,et al.  Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. , 1997, Journal of the American College of Cardiology.

[23]  Felix Zijlstra,et al.  Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction , 1997, The Lancet.

[24]  F Van de Werf,et al.  Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. , 1996, Journal of the American College of Cardiology.

[25]  L. Hue,et al.  Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. , 1995, Circulation.

[26]  Fibrinolytictherapytrialistsf.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[27]  V. Richard,et al.  Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. , 1993, The American journal of cardiology.

[28]  R. Califf,et al.  Continuous 12‐Lead ST‐Segment Recovery Analysis in the TAMI 7 Study Performance of a Noninvasive Method for Real‐Time Detection of Failed Myocardial Reperfusion Detection of Failed Myocardial Reperfusion , 1993, Circulation.

[29]  P. Théroux,et al.  Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion. , 1987, Cardiovascular research.

[30]  E. Lesaffre,et al.  Determinants of infarct size in non-human primates , 2005, Basic Research in Cardiology.

[31]  A. Hoes.  Case-control studies. , 1995, The Netherlands journal of medicine.

[32]  P. Shah,et al.  Angiographic validation of bedside markers of reperfusion. , 1993, Journal of the American College of Cardiology.